Details:

Alternative Title:
AIDS
Personal Author:
Moyo, Sikhulile ; Gaseitsiwe, Simani ; Powis, Kathleen M ; Holme, Molly Pretorius ; Mohammed, Terence ; ... More +
Moyo, Sikhulile ; Gaseitsiwe, Simani ; Powis, Kathleen M ; Holme, Molly Pretorius ; Mohammed, Terence ; Zahralban-Steele, Melissa ; Yankinde, Etienne Kadima ; Maphorisa, Comfort ; Abrams, William ; Lebelonyane, Refeletswe ; Manyake, Kutlo ; Sekoto, Tumalano ; Mmalane, Mompati ; Gaolathe, Tendani ; Wirth, Kathleen E. ; Makhema, Joseph ; Lockman, Shahin ; Clarke, William ; Essex, Max ; Novitsky, Vlad Less -
Description:
: Among 3596 HIV-positive participants enrolled in the Botswana Combination Prevention Project who self-reported no prior antiretroviral (ARV) therapy use and were tested for viral load (n = 951; 27% of all participants), 136 (14%) had HIV-1 RNA less than 400 copies/ml. ARV drugs were detected in 52 (39%) of 134 participants tested. Adjusting for undisclosed ARV use increased the overall estimate of virally suppressed individuals on ARV therapy by 1.4% from 70.2 to 71.6%.
Subject:
[+]
Antiretroviral Drugs (ARVs)
Antiretroviral Therapy (ART)
Article
Estimate Of Virally Suppressed
Undisclosed ART Use

Source:
AIDS. 32(11):1543-1546
Pubmed ID:
29762166
Pubmed Central ID:
PMC6047897
Document Type:
Journal Article
Funding:
U01 GH000447/GH/CGH CDC HHS/United States ; K24 AI131928/AI/NIAID NIH HHS/United States ; D43 TW010543/TW/FIC NIH HHS/United States ; U2G GH001911/GH/CGH CDC HHS/United States ; Wellcome Trust/United Kingdom
U01 GH000447/GH/CGH CDC HHS/United States ; K24 AI131928/AI/NIAID NIH HHS/United States ; D43 TW010543/TW/FIC NIH HHS/United States ; U2G GH001911/GH/CGH CDC HHS/United States ; Wellcome Trust/United Kingdom Less -
Place as Subject:
Botswana
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:8ddb22d8e0a4998e2357198ab98876d972cbb62207bcb05207675ae87cc9764c
File Type:

Supporting Files

• nihms976992.nxml

  xml

More +